Decoding Immune Mechanisms in BCG-unresponsive Non-muscle Invasive Bladder Cancer
Non-muscle-invasive bladder cancer (NMIBC) accounts for roughly 75% of all bladder cancer cases. For patients with intermediate- and high-risk disease, intravesical Bacillus Calmette-Guérin (BCG) remains the standard treatment, yet it fails in up to 40% of cases. While radical cystectomy is the most...
Gardado en:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
IMR Press
2026-04-01
|
| Series: | Frontiers in Bioscience-Landmark |
| Assuntos: | |
| Acceso en liña: | https://www.imrpress.com/journal/FBL/31/5/10.31083/FBL47606 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|